Tom Oostrom of the Dutch Kidney Foundation Shares NeXtkidney Updates

The Dutch Kidney Foundation initiated NeXtkidney, a carry-on-sized HD machine, in 2012. Outcomes of the first clinical trial were good, and more trials will take place in France and the Netherlands in 2025. The goal is to get FDA approval to market NeXtkidney in the U.S.

Read the full article » | Posted 02-14-2025

Related Articles

• Proof of Concept for Silicon Nanopore Membrane Implantable HD Posted 10-05-2026
• AWAK PD To Go Posted 10-05-2026
• The Lancet Digital Health published results of Humacyte’s Phase III clinical trial of its V007 acellular tissue engineered vessel (ATEV) HD access Posted 09-18-2026
• Humacyte, Inc. announced Robert J. Kossman, MD, FACP, FASN and Prabir Roy-Chaudhury, MD, PhD, FASN have joined the company as advisors. Posted 08-21-2026